Patents by Inventor Michael J. Torres

Michael J. Torres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250064752
    Abstract: In some aspects, the present disclosure provides a nanoparticle composition comprising tRNA and an aminolipid delivery compound. The aminolipid delivery compound may be a dendrimer, dendron, or dendritic lipid, a polymer such as a polyamide or polyester, or a lipid with one or more hydrophobic components. In some embodiments, these compositions may be administered to a patient to treat a genetic disease or disorder such as cystic fibrosis, Duchene muscular dystrophy, or cancer.
    Type: Application
    Filed: October 29, 2024
    Publication date: February 27, 2025
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Daniel J. SIEGWART, Philip J. THOMAS, Arthur E. JOHNSON, Michael J. TORRES, Jason B. MILLER
  • Publication number: 20210023120
    Abstract: In some aspects, the present disclosure provides a nanoparticle composition comprising tRNA and an aminolipid delivery compound. The aminolipid delivery compound may be a dendrimer, dendron, or dendritic lipid, a polymer such as a polyamide or polyester, or a lipid with one or more hydrophobic components. In some embodiments, these compositions may be administered to a patient to treat a genetic disease or disorder such as cystic fibrosis, Duchene muscular dystrophy, or cancer.
    Type: Application
    Filed: October 6, 2020
    Publication date: January 28, 2021
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Daniel J. Siegwart, Philip J. Thomas, Arthur E. Johnson, Michael J. Torres, Jason B. Miller
  • Publication number: 20170354672
    Abstract: In some aspects, the present disclosure provides a nanoparticle composition comprising tRNA and an aminolipid delivery compound. The aminolipid delivery compound may be a dendrimer, dendron, or dendritic lipid, a polymer such as a polyamide or polyester, or a lipid with one or more hydrophobic components. In some embodiments, these compositions may be administered to a patient to treat a genetic disease or disorder such as cystic fibrosis, Duchene muscular dystrophy, or cancer.
    Type: Application
    Filed: May 16, 2017
    Publication date: December 14, 2017
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Daniel J. Siegwart, Philip J. Thomas, Arthur E. Johnson, Michael J. Torres, Jason B. Miller
  • Patent number: 6156250
    Abstract: Fully dense composite accurate tooling is manufactured by casting but without the requirement of subsequent machining. The tooling so provided by the invention comprises injection mold halves for mating engagement to form a mold for injecting multiple near net shapes using either thermoset or thermoplastic materials. A known vacuum casting technique used for producing parts has been modified to make tooling according to the invention. A master pattern of the near net shape or a model of the actual core and cavity of the desired mold is used to create a silicone rubber mold (SRM). Once the SRM is completed, the 3-part material (catalyst, resin and composite) is weighed to the required volume to cast into the SRM, then placed (along with the SRM) into the vacuum casting system which reaches a level of 28 inches Hg of vacuum. The 3-part composite material is thoroughly mixed for approximately 20 minutes in about 28 inches Hg of vacuum.
    Type: Grant
    Filed: January 4, 1999
    Date of Patent: December 5, 2000
    Assignee: MCP Metalspecialties, Inc.
    Inventors: Michael J. Torres, Michael F. Wells